Skip to main content

Advertisement

Log in

Underinsurance for Recently Recommended Vaccines in Private Health Plans

  • Original Paper
  • Published:
Journal of Community Health Aims and scope Submit manuscript

Abstract

Underinsurance for vaccines presents financial barriers to vaccination. Preventive services coverage is of interest in national healthcare reform. To assess vaccine benefits coverage in private health plans. Private health insurance carriers were surveyed December 2008–June 2009 on policies regarding vaccine coverage in fully insured plans. Carriers were identified as multi-state, state-specific Blue Cross or local-independent carriers. Plan types included HMO, PPO, POS and ‘other.’ Full benefits coverage was defined as having benefits without a copay or coinsurance for a recommended vaccine. Analyses were conducted to examine associations between carrier type, plan type, and full benefits coverage. Fifty-one carriers (response rate = 56 %) provided data for 78 unique plans, reflecting over 47 million private plan enrollees. Full benefits coverage was highest for combined tetanus/diphtheria/acellular pertussis (74 %) and lower for pneumococcal conjugate (72 %), rotavirus (72 %), human papillomavirus (71 %), hepatitis A (68 %), meningococcal conjugate (67 %), inactivated influenza (67 %), live attenuated influenza (63 %) and zoster (57 %) vaccines. Compared with plans offered by state-specific Blue Cross carriers, significantly higher proportions of multi-state carriers and local independent carriers had plans with full benefits coverage for vaccines (p < 0.05). Compared with PPO and “other” plans, significantly higher proportions of HMO and POS plans had full benefits coverage for vaccines (p < 0.05). In this national study, levels of underinsurance for immunization leave room for improvement. State-specific Blue Cross plans and indemnity or high-deductible plans are least likely to offer full coverage for recently recommended vaccines, and may face changes with incorporation of “essential health benefits” requirements.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Institute of Medicine. (2003). Financing vaccines in the 21st century: Assuring access and availability. Washington, DC: National Academies Press.

    Google Scholar 

  2. Orenstein, W. A., Douglas, R. G., Rodewald, L. E., & Hinman, A. R. (2005). Immunizations in the United States: Success, structure, and stress. Health Affairs (Millwood), 24, 599–610.

    Article  Google Scholar 

  3. Davis, M. M., Zimmerman, J. L., Wheeler, J. R. C., & Freed, G. L. (2002). The costs of childhood vaccine purchase in the public sector: Past trends, future expectations. American Journal of Public Health, 92, 1982–1987.

    Article  PubMed  Google Scholar 

  4. Davis, M. M. (2010). Price as a double-edged sword in the golden era of vaccines. Human Vaccines, 6, 689–693.

    Article  Google Scholar 

  5. Smith, P. J., Molinari, N.-A., & Rodewald, L. E. (2009). Underinsurance and pediatric immunization delivery in the United States. Pediatrics, 124, S507–S514.

    Article  PubMed  Google Scholar 

  6. Shen, A. K., Hunsaker, J., Gazmararian, J. A., Lindley, M. C., & Birkhead, G. S. (2009). Role of health insurance in financing vaccinations for children and adolescents in the United States. Pediatrics, 124, S522–S531.

    Article  PubMed  Google Scholar 

  7. Centers for Disease Control and Prevention. (2010). Recommended adult immunization schedule—United States. MMWR. Morbidity and Mortality Weekly Report, 59, 1–4.

    Google Scholar 

  8. Centers for Disease Control and Prevention. (2010). Recommended immunization schedules for persons aged 0 through 18 years—United States, 2010. MMWR. Morbidity and Mortality Weekly Report, 58, 1–4.

    Google Scholar 

  9. Patient Protection and Affordable Care Act. (2010). Public Law 111–148. Text available at http://democrats.senate.gov/reform/patient-protection-affordable-care-act-as-passed.pdf. Accessed April 4, 2011.

  10. Institute of Medicine. (2011). Essential health benefits—balancing coverage and cost. Available at http://www.iom.edu/~/media/Files/Report%20Files/2011/Essential-Health-Benefits-Balancing-Coverage-and-Cost/essentialhealthbenefitsreportbrief4.pdf. Accessed November 15, 2011.

Download references

Acknowledgments

This study was supported by Cooperative Agreement Number U48 DP000055 from the Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Conflict of interest

The authors have no conflicts of interest to report.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dianne C. Singer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Singer, D.C., Davis, M.M., Gebremariam, A. et al. Underinsurance for Recently Recommended Vaccines in Private Health Plans. J Community Health 37, 1164–1167 (2012). https://doi.org/10.1007/s10900-012-9567-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10900-012-9567-7

Keywords

Navigation